ADPT · Categories · Downgrades
ADPT - Analyst downgrades
Adaptive Biotechnologies Corporation (ADPT) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for ADPT
- Adaptive Biotechnologies downgraded by The Goldman Sachs Group with a new price targetThe Goldman Sachs Group downgraded Adaptive Biotechnologies from Buy to Neutral and set a new price target of $63.00 from $74.00 previously
- Adaptive Biotechnologies downgraded by The Goldman Sachs GroupThe Goldman Sachs Group downgraded Adaptive Biotechnologies from Buy to Neutral
- Adaptive Biotechnologies downgraded by Goldman with a new price targetGoldman downgraded Adaptive Biotechnologies from Buy to Neutral and set a new price target of $63.00 from $74.00 previously